Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06208735
Title CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors British Columbia Cancer Agency
Age Groups: child | senior | adult
Covered Countries CAN

No variant requirements are available.